DYNACTION 
By 2012 FIRST-HALF SALES
Longjumeau, July 23rd, 2012
Business buoyant over the first half of 2012
(in thousands of euros) H1-2012 H1-2011 % change
Sales 89 361 85 842 +4.1% including Pharmaceutical Synthesis 55 364 53 604 +3.3% including Fine Speciality Chemicals 33 997 32 238 +5.5%
(unaudited data)
The Dynaction Group achieved 4.1% growth in consolidated
sales for the first half of 2012 compared with 2011.
Pharmaceutical Synthesis
Revenues are up 3.3%. Excluding the contract between PCAS and Sanofi, this division's sales increased by 7.7% compared with the first half of 2011.
Fine Specialty Chemicals
The Fine Specialty Chemicals business has recorded 5.5%
growth over 2012, driven by New Technologies lines, while the
Performance Chemicals and Fragrance-Flavor-Cosmetics
activities contracted slightly over the period.
As a result, the Group's earnings at the end of June 2012
will come in significantly higher than the first half of
2011.
The second half of the year should see as well an increase of
volume of business, stronger than the second half of
2011.
The full consolidated half-year accounts will be reviewed and
approved by the Board of Directors on September 6th.
About Dynaction :
Dynaction is an industrial holding company focused on a unique development pole: Fine Speciality
Chemicals, a field of its subsidiary PCAS and in which it holds a majority share of 61.08 %.
CONTACT : PHILIPPE D ELWASSE , CEO | +33 (0)1 69 79 60 62 | WWW . DYNACTION . FR
|
distributed by
|
